Home › Compare › KMNCF vs ABBV
KMNCF yields 3.66% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, KMNCF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KMNCF + ABBV for your $10,000?
Kingsmen Creatives Ltd., an investment holding company, engages in exhibitions and thematic, retail and corporate interiors, research and design, and alternative marketing businesses. The company's Exhibitions and Thematic segment produces exhibition displays for trade shows and promotional events; interiors and displays for museums and visitor centers; and thematic and scenic displays for theme parks, as well as develops and operates intellectual property for experimental and themed attractions. Its Retail and Corporate Interiors segment provides interior fitting-out services to retail and commercial properties. The company's Research and Design segment offers design works for upmarket specialty stores, departmental stores, eateries, museums, visitors' centers, corporate offices, showrooms, trade shows, events, promotional functions, and festivals. Its Alternative Marketing segment provides event management, branding consultancy, and custom publishing services. In addition, the company provides design consultancy and planning management, exhibition organizers, consultancy event management, advertising, marketing communications, electrical engineering, and graphic design and production services, as well as design and construction facilities to exhibitors. Further, it designs and produces architectural interiors, decorations, and museums; operates as an advertising contractor and agent; provides corporate marketing and other related services; and manufactures, trades, and wholesales interior and exhibition furniture, fixtures, and displays. The company operates in South Asia, North Asia, the Middle East, the United States, Canada, Europe, and internationally. Kingsmen Creatives Ltd. was founded in 1976 and is headquartered in Singapore.
Full KMNCF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.